Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 37.96%
December 31, 2025 45.65%
September 30, 2025 42.97%
June 30, 2025 68.23%
March 31, 2025 58.07%
December 31, 2024 -16.54%
September 30, 2024 36.70%
June 30, 2024 62.24%
March 31, 2024 55.10%
December 31, 2023 59.41%
September 30, 2023 44.04%
June 30, 2023 52.31%
March 31, 2023 54.86%
December 31, 2022 69.64%
September 30, 2022 69.08%
June 30, 2022 45.37%
March 31, 2022 75.67%
December 31, 2021 78.26%
September 30, 2021 78.18%
June 30, 2021 78.68%
March 31, 2021 79.72%
December 31, 2020 78.91%
September 30, 2020 78.54%
June 30, 2020 78.34%
March 31, 2020 77.22%
Date Value
December 31, 2019 78.37%
September 30, 2019 77.18%
June 30, 2019 77.25%
March 31, 2019 76.38%
December 31, 2018 77.13%
September 30, 2018 75.23%
June 30, 2018 75.29%
March 31, 2018 75.37%
December 31, 2017 74.74%
September 30, 2017 74.46%
June 30, 2017 74.41%
March 31, 2017 75.80%
December 31, 2016 73.28%
September 30, 2016 73.58%
June 30, 2016 72.65%
March 31, 2016 72.20%
December 31, 2015 65.45%
September 30, 2015 64.26%
June 30, 2015 62.81%
March 31, 2015 63.41%
December 31, 2014 63.27%
September 30, 2014 60.60%
June 30, 2014 58.45%
March 31, 2014 59.30%
December 31, 2013 57.18%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Akari Therapeutics Plc --
Cellectis SA 21.50%
Agenus, Inc. 98.27%
Grifols SA 36.47%
Trinity Biotech Plc 32.05%

Gross Profit Margin (Quarterly) Related Metrics